Pharmaceutical

Filter

Current filters:

None

Popular Filters

80 to 104 of 7216 results

Indian drugmaker Venus sets out pre-budget expectations

Indian drugmaker Venus sets out pre-budget expectations

19-02-2015

The Union Finance Minister should take his government’s “Make in India” campaign to the next level…

FinancialIndiaPharmaceuticalPoliticsResearchVenus Remedies

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

Ferring Pharma acquires two Ph III-ready orthobiologics from BioSET

19-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has acquired the assets of USA-based…

AmplexFerring PharmaceuticalsLicensingPharmaceuticalPrefixSwitzerland

NICE final draft guidance recommends Norgine's Targaxan

NICE final draft guidance recommends Norgine's Targaxan

19-02-2015

The UK’s National Institute for Health and Care Excellence has published its final draft guidance recommending…

Nephrology and HepatologyNeurologicalNorginePharmaceuticalRegulationTargaxanUK

Pharma violates own marketing regulations, Swedish study alleges

Pharma violates own marketing regulations, Swedish study alleges

19-02-2015

A new report from Lund University in Sweden claims to show how the pharmaceutical industry, time and…

Markets & MarketingPharmaceuticalRegulationSwedenUK

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Former pharma execs set up financing strategy partnership

Former pharma execs set up financing strategy partnership

18-02-2015

Three former pharma and health care executives have formed a new partnership to provide strategic support…

Business FinanceFinancialnext20PharmaceuticalUSA

Sanofi collaborates with Lead Pharma for autoimmune disease development

Sanofi collaborates with Lead Pharma for autoimmune disease development

18-02-2015

French pharma major Sanofi has entered into a research collaboration and license agreement with privately-held…

Anti-Arthritics/RheumaticsLead PharmaLicensingPharmaceuticalResearchSanofi

Use of generics key to glaucoma medicine adherence, study says

Use of generics key to glaucoma medicine adherence, study says

18-02-2015

A potential solution to resolve patient non-adherence in glaucoma treatment is switching to generic drugs,…

Bimatoprost Ophthalmic Solution 0.03% for GlaLatanoprost OphthalmicOphthalmicsPharmaceuticalPricingResearchUSA

VBL Therapeutics shares slide as it ends VB-201 development in two indications

VBL Therapeutics shares slide as it ends VB-201 development in two indications

18-02-2015

Shares in Israeli drugmaker VBL Therapeutics dropped up to 55% after it said that it would discontinue…

Gastro-intestinalsIsraelOncologyPharmaceuticalResearchVBL Therapeutics

Pharming appoints Perry Calias as chief scientific officer

Pharming appoints Perry Calias as chief scientific officer

18-02-2015

Dutch pharma company Pharming has appointed Perry Calias as chief scientific officer.

BoardroomNetherlandsPerry CaliasPharmaceuticalPharming

FDA issues new draft documents related to compounding of human drugs

FDA issues new draft documents related to compounding of human drugs

17-02-2015

The US Food and Drug Administration issued five draft documents related to drug compounding and repackaging…

FDAHealthPharmaceuticalPharmaceutical sciencesPharmacologyRegulationSterile compounded drug productsUSA

EC withdraws investigation of UK’s Patent Box scheme

EC withdraws investigation of UK’s Patent Box scheme

17-02-2015

The European Commission has decided to withdraw its investigation into the UK government's Patent Box…

LegalPharmaceuticalUKUK governmentUnited Kingdom

Sprout Pharmaceuticals resubmits flibanserin to the FDA for women's hypoactive sexual desire disorder

Sprout Pharmaceuticals resubmits flibanserin to the FDA for women's hypoactive sexual desire disorder

17-02-2015

Privately-held US sexual health specialists Sprout Pharmaceuticals has resubmitted its New Drug Application…

flibanserinPharmaceuticalRegulationSprout PharmaceuticalsUSAWomen's Health

Insomnia drug market set to take major hit to 2016, with only partial recovery by 2023

Insomnia drug market set to take major hit to 2016, with only partial recovery by 2023

17-02-2015

The insomnia drug market is set to fall rapidly by 2016 but will partially recover by 2023, says research…

BelsomraLunestaMarkets & MarketingNeurologicalPatentsPatents & Trade marksPharmaceutical

FDA conference highlights: Agency focuses on pediatric therapies to treat rare diseases

FDA conference highlights: Agency focuses on pediatric therapies to treat rare diseases

17-02-2015

In a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks the…

FDAPharmaceuticalPharmacologyRegulationUSA

Takeda motesanib fails to meet primary endpoint in Ph III NSCLC study

Takeda motesanib fails to meet primary endpoint in Ph III NSCLC study

17-02-2015

In a second research negative this month, Japan’s largest drugmaker Takeda Pharmaceutical has today…

JapanmotesanibOncologyPharmaceuticalResearchTakeda Pharmaceutical

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

17-02-2015

UK pharma major GlaxoSmithKline has named Jack Bailey as president of its US pharma unit.

BoardroomGSKPharmaceuticalUnited StatesUSA

Fresenius Kabi sells German oncology compounding business

Fresenius Kabi sells German oncology compounding business

17-02-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has sold its German subsidiary CFL…

CFLFreseniusFresenius KabiGermanyMergers & AcquisitionsNewCo PharmaOncologyPharmaceutical

Overview of Mexico’s pharmaceutical market

Overview of Mexico’s pharmaceutical market

17-02-2015

The improving regulatory environment and the increasing foreign direct investment make Mexico's pharmaceutical…

EspicomHealthcareMarkets & MarketingMexicoPharmaceutical

Alzheimer’s Research UK launches £30m Drug Discovery Alliance

Alzheimer’s Research UK launches £30m Drug Discovery Alliance

16-02-2015

Dementia research charity Alzheimer’s Research UK has announced a £30 million ($46 million) Drug Discovery…

Aging-associated diseasesNeurologicalPharmaceuticalResearchUK

Pharma pricing regulation puts Spain 15% lower than Eurozone average

Pharma pricing regulation puts Spain 15% lower than Eurozone average

16-02-2015

The average price per standard unit of medicine in Spain was 15% lower than the average of Eurozone countries…

EuropePharmaceuticalPharmaceutical industryPricingSpain

Sanofi could name Bayer's Olivier Brandicourt as new chief executive, sources say

Sanofi could name Bayer's Olivier Brandicourt as new chief executive, sources say

16-02-2015

Sources say that Olivier Brandicourt, the current head of healthcare at German drug major Bayer, is the…

BayerFranceManagementPharmaceuticalSanofi

In 2014, Finland’s pharma market saw steady development

16-02-2015

Last year, the pharmacy and hospital sectors of the Finnish pharmaceutical market grew relatively steadily,…

FinlandMarkets & MarketingPharmaceuticalPricing

80 to 104 of 7216 results

COMPANY SPOTLIGHT

Menarini

Back to top